PapersPMID:26654905
The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo-controlled trial.
No finding here moved its endpoint.
What did not
1 findingHow to read these marks →“The percentage of infants classified as low birth weight (<2500 g) or small for gestational age or large for gestational age, or with a neonatal complication or major congenital abnormality, did not differ between the treatment and placebo groups (Table 4).”
- Study
- RCT
- Dose studied
- 150 μg iodine as potassium iodide, one tablet daily from randomisation to end of pregnancy
- Population
- Infants of 59 pregnant women in Adelaide, Australia, randomised before 20 weeks of gestation to iodine or placebo; a trial stopped early after funding withdrawal
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Pregnant women under 20 weeks' gestation with a singleton pregnancy, Adelaide, Australia
- Participants
- 59
- Comparator
- placebo
- Duration
- 112 days
- Endpoints measured
- 36